Phase
Condition
Stroke
Cerebral Ischemia
Treatment
Transtemporal ultrasound with contrast product (Sonovue)
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient aged 18 and over
Hospitalized patient with ischemic stroke in the deep territory of the middlecerebral artery
Patient with lesion observable on MRI
Patient included between 24 hours and 7 days after the ischemic stroke
Patient with a temporal window which allows soundproofing of the polygon of Willisand the middle cerebral artery
Patient having signed free, informed and written consent
Patient affiliated to a social security system (excluding AME)
Exclusion
Exclusion Criteria:
Contralateral middle cerebral artery territory stroke or contralateral middlecerebral artery occlusion
Patient with contraindication to Doppler ultrasound with contrast (right-left shunt,severe pulmonary arterial hypertension)
Patient with hypersensitivity to the active princip of Sonovue (sulfur hexafluoride)or these excipients
Patient with uncontrolled systemic hypertension
Patient with respiratory distress syndrome
Patient under guardianship or curatorship
Pregnant or breastfeeding patient (positive blood pregnancy test duringhospitalization)
Patient with damaged skin at the temporal level
Patient having presented in the 7 days preceding inclusion an acute coronarysyndrome or suffering from unstable ischemic heart disease
Study Design
Connect with a study center
Hôpital Bichat
Paris, Ile de France 75018
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.